These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37461378)

  • 1. Cost-Effectiveness of Group Transdiagnostic Cognitive Behavioural Therapy for Anxiety Disorders in Primary Care Settings: Economic Evaluation From the Healthcare System Perspective Over a 1-Year Time Horizon.
    Vasiliadis HM; Lamoureux-Lamarche C; Chapdelaine A; Provencher MD; Norton PJ; Berbiche D; Roberge P
    Can J Psychiatry; 2024 Jan; 69(1):43-53. PubMed ID: 37461378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy for anxiety disorders
    Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
    Psychol Med; 2023 Oct; 53(14):6570-6582. PubMed ID: 36695038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderators of the cost-effectiveness of transdiagnostic CBT for anxiety disorders over an 8-month time horizon using a net-benefit regression framework.
    Chapdelaine A; Vasiliadis HM; Provencher MD; Norton PJ; Roberge P
    BMC Health Serv Res; 2023 Jun; 23(1):596. PubMed ID: 37291599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pragmatic randomized controlled trial of group transdiagnostic cognitive-behaviour therapy for anxiety disorders in primary care: study protocol.
    Roberge P; Provencher MD; Gosselin P; Vasiliadis HM; Gaboury I; Benoit A; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
    BMC Psychiatry; 2018 Oct; 18(1):320. PubMed ID: 30285672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
    McCrone P; Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    BMC Gastroenterol; 2021 Jul; 21(1):276. PubMed ID: 34229619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia.
    Livingston G; Barber J; Rapaport P; Knapp M; Griffin M; Romeo R; King D; Livingston D; Lewis-Holmes E; Mummery C; Walker Z; Hoe J; Cooper C
    Health Technol Assess; 2014 Oct; 18(61):1-242. PubMed ID: 25300037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group transdiagnostic cognitive-behavior therapy for anxiety disorders: a pragmatic randomized clinical trial.
    Roberge P; Provencher MD; Gaboury I; Gosselin P; Vasiliadis HM; Benoît A; Carrier N; Antony MM; Chaillet N; Houle J; Hudon C; Norton PJ
    Psychol Med; 2020 Dec; 52(13):1-11. PubMed ID: 33261700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.
    Kaltenthaler E; Brazier J; De Nigris E; Tumur I; Ferriter M; Beverley C; Parry G; Rooney G; Sutcliffe P
    Health Technol Assess; 2006 Sep; 10(33):iii, xi-xiv, 1-168. PubMed ID: 16959169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized controlled trial.
    Romijn G; Riper H; Kok R; Donker T; Goorden M; van Roijen LH; Kooistra L; van Balkom A; Koning J
    BMC Psychiatry; 2015 Dec; 15():311. PubMed ID: 26651478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A supported self-help for recurrent depression in primary care; An economic evaluation alongside a multi-center randomised controlled trial.
    Biesheuvel-Leliefeld KEM; Bosmans JE; Dijkstra-Kersten SMA; Smit F; Bockting CLH; van Schaik DJF; van Marwijk HWJ; van der Horst HE
    PLoS One; 2018; 13(12):e0208570. PubMed ID: 30566441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
    Witlox M; Kraaij V; Garnefski N; Bohlmeijer E; Smit F; Spinhoven P
    PLoS One; 2022; 17(1):e0262220. PubMed ID: 35081130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of transdiagnostic group cognitive behavioural therapy versus group relaxation therapy for emotional disorders in primary care (PsicAP-Costs2): Protocol for a multicentre randomised controlled trial.
    González-Blanch C; Barrio-Martínez S; Priede A; Martínez-Gómez S; Pérez-García-Abad S; Miras-Aguilar M; Ruiz-Gutiérrez J; Muñoz-Navarro R; Ruiz-Rodríguez P; Medrano LA; Prieto-Vila M; Carpallo-González M; Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Moriana JA; Cano-Vindel A
    PLoS One; 2023; 18(3):e0283104. PubMed ID: 36928238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic Evaluation of Concise Cognitive Behavioural Therapy and/or Pharmacotherapy for Depressive and Anxiety Disorders.
    Meuldijk D; Carlier IV; van Vliet IM; van Hemert AM; Zitman FG; van den Akker-van Marle ME
    J Ment Health Policy Econ; 2015 Dec; 18(4):175-83. PubMed ID: 26729009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
    Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
    Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic Evaluation of an Internet-Based Preventive Cognitive Therapy With Minimal Therapist Support for Recurrent Depression: Randomized Controlled Trial.
    Klein NS; Bockting CL; Wijnen B; Kok GD; van Valen E; Riper H; Cuijpers P; Dekker J; van der Heiden C; Burger H; Smit F
    J Med Internet Res; 2018 Nov; 20(11):e10437. PubMed ID: 30478021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness and cost-utility evaluation of individual vs. group transdiagnostic psychological treatment for emotional disorders in primary care (PsicAP-Costs): a multicentre randomized controlled trial protocol.
    Aguilera-Martín Á; Gálvez-Lara M; Cuadrado F; Moreno E; García-Torres F; Venceslá JF; Corpas J; Jurado-González FJ; Muñoz-Navarro R; González-Blanch C; Ruiz-Rodríguez P; Barrio-Martínez S; Prieto-Vila M; Carpallo-González M; Cano-Vindel A; Moriana JA
    BMC Psychiatry; 2022 Feb; 22(1):99. PubMed ID: 35139809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.